Dr. Clark is the Medical Director of Transfusion Medicine at the University of Tennessee Medical Center.

This is the first installment in what will be a regular series of questions and answers with blood industry thought leaders.  This installment looks at Acrodose, an FDA-approved whole blood derived alternative to apheresis Single Donor Platelets.